Table 2 Five-year relative survival (%) of patients with haematological malignancies^a diagnosed at age 13–24 during 1979–2001 in England

	ALL			AML			CML			NHL			HL
	N	%	P	N	%	P	N	%	P	N	%	P	N	%	P
Sex
Male	1163	43	0.019	671	36	0.074	178	50	0.690	1552	65	0.206	3055	87	0.026
Female	633	50		565	42		116	54		789	68		2794	89
Age (years)
13–16	869	50	<0.001	333	40	0.536	54	43	0.372	599	70	0.033	1045	89	0.550
17–20	581	44		439	39		94	54		816	65		2132	88
21–24	346	37		464	38		146	54		926	66		2672	88
Deprivation
Most affluent	361	48	0.066	255	39	0.253	45	73	0.173	457	62	0.813	1248	90	0.190
2	400	48		240	43		53	43		452	69		1183	86
3	313	48		260	35		52	47		453	69		1210	86
4	371	43		252	41		62	51		457	66		1113	89
Most deprived	351	42		229	36		82	50		522	65		1095	87
Year of diagnosis
1979–1984	490	37	<0.001	311	27	<0.001	64	30	0.002	506	52	<0.001	1525	85	<0.001
1985–1989	416	45		259	34		71	62		569	70		1495	86
1990–1995	457	48		351	43		77	51		629	68		1492	89
1996–2001	433	55		315	50		82	66		637	72		1337	93

ALL=acute lymphoid leukaemia; AML=acute myeloid leukaemia; CML=chronic myeloid leukaemia; HL=Hodgkin lymphoma; NHL=non-Hodgkin lymphoma.
^aExcluding 196 cases with other rare and unspecified haematological malignancies.

Quick links

Search